Assembly Biosciences (ASMB) Gains from Investment Securities (2015 - 2025)

Assembly Biosciences' Gains from Investment Securities history runs 11 years deep, the most recent figure standing at $225000.0 for Q4 2025.

• In Q4 2025, Gains from Investment Securities fell 88.56% year-over-year to $225000.0; the TTM figure through Dec 2025 stood at $225000.0 (down 88.56% YoY), while the FY2025 annual figure was $225000.0, down 76.12% from the prior year.
• Gains from Investment Securities was $225000.0 for Q4 2025 at Assembly Biosciences, roughly flat from $225000.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $9.4 million in Q3 2022 to a low of -$1.6 million in Q1 2021.
• Historically, Gains from Investment Securities has averaged $1.5 million across 5 years, with a median of $299000.0 in 2022.
• The sharpest annual moves came in 2021 and 2022: Gains from Investment Securities plunged 545.03% in 2021, then surged 536.04% in 2022.
• A 5-year view of Gains from Investment Securities shows it stood at $2.8 million in 2021, then tumbled by 90.83% to $261000.0 in 2022, then increased by 29.12% to $337000.0 in 2023, then surged by 483.38% to $2.0 million in 2024, then sank by 88.56% to $225000.0 in 2025.
• The last three Gains from Investment Securities figures came in at $225000.0 (Q4 2025), $225000.0 (Q3 2025), and $225000.0 (Q2 2025), per Business Quant data.